CA Stock MarketDetailed Quotes

CVR Medical Corp (CVM)

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayMarket Closed Sep 18 09:30 ET
0Market Cap0.00P/E (TTM)

CVR Medical Corp (CVM) Cash Flow

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2022/Q2
2022/Q1
2021/Q4
2021/Q3
2021/Q2
2021/Q1
2020/Q4
2020/Q3
2020/Q2
2020/Q1
2019/Q4
2019/Q3
2019/Q2
2019/Q1
2018/Q4
2018/Q3
2018/Q2
2018/Q1
2017/Q4
2017/Q3
Operating Cash Flow
-429.83%-93.67K
-471.84%-52.46K
-114.61%-51.32K
+68.12%-56.30K
+112.62%28.40K
+92.94%-9.17K
+307.29%351.18K
-805.02%-176.62K
+70.64%-225.07K
+89.58%-129.92K
+90.68%-169.41K
+96.48%-19.52K
+29.11%-766.56K
-37.17%-1.25M
-264.64%-1.82M
+37.57%-554.37K
-4.97%-1.08M
+38.16%-908.83K
+38.01%-498.26K
-1000.89%-888.05K
Net cash flow from continuing operations
-429.83%-93.67K
-471.84%-52.46K
-114.61%-51.32K
+68.12%-56.30K
+112.62%28.40K
+92.94%-9.17K
+307.29%351.18K
-805.02%-176.62K
+70.64%-225.07K
+89.58%-129.92K
+90.68%-169.41K
+96.48%-19.52K
+29.11%-766.56K
-37.17%-1.25M
-264.64%-1.82M
+37.57%-554.37K
-4.97%-1.08M
+38.16%-908.83K
+38.01%-498.26K
-1000.89%-888.05K
Net Income from Continuing Operations
-229.04%-190.59K
+59.86%-134.88K
-268.87%-1.39M
+21.88%-243.52K
+145.07%147.70K
+5.23%-335.99K
+167.57%820.62K
-14.52%-311.74K
+80.03%-327.74K
+82.35%-354.54K
+61.11%-1.21M
+77.25%-272.22K
+5.33%-1.64M
-44.64%-2.01M
-176.42%-3.12M
+5.09%-1.20M
+1.51%-1.73M
+42.15%-1.39M
+21.55%-1.13M
-69.49%-1.26M
Depreciation & Depletion & Amortization
-100.00%0.00
-49.18%31.00
+3.33%62.00
+6.90%62.00
+12.50%63.00
+5.17%61.00
+1.69%60.00
-1.69%58.00
-3.45%56.00
+0.00%58.00
+90.32%59.00
-32.18%59.00
-1.69%58.00
-6.45%58.00
-42.18%31.00
+29.48%87.00
-1.58%59.00
+112.01%62.00
--53.62
--67.19
Asset Impairment Expenditure
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-190.89%-569.32K
-4.26%316.29K
-26.52%585.06K
-40.36%491.20K
-4.53%626.40K
--330.38K
Stock-Based Compensation
+98.98%-2.34K
-88.90%15.22K
+105.59%32.00K
-83.29%18.01K
-321.40%-230.31K
+21.98%137.15K
-300.36%-571.91K
+118.51%107.81K
-74.72%104.03K
-82.08%112.44K
-76.97%285.44K
---582.39K
--411.47K
--627.31K
+9067.39%1.24M
-100.00%0.00
-100.00%0.00
-100.00%0.00
+147.32%13.52K
-98.74%11.10K
Other Non-Cash Items
-3.68%9.65K
-3.67%9.19K
---39.42K
--10.51K
--10.01K
--9.54K
----
----
----
----
----
----
----
----
----
----
----
----
---17.40K
--3.63K
Change in Working Capital
-11.23%89.61K
-67.81%57.97K
+200.81%169.07K
+482.13%158.64K
+7228.74%100.94K
+60.60%180.07K
-90.95%56.21K
-96.74%27.25K
-100.31%-1.42K
-17.03%112.12K
-6.13%620.98K
+156.13%835.03K
+588.12%463.28K
+1327.89%135.13K
+7468.12%661.56K
+1078.56%326.02K
+144.37%67.33K
+80.98%-11.01K
+205.83%8.74K
-42.12%27.66K
-Change in Receivables
+97.70%-67.00
-154.01%-602.00
+59.71%-365.00
+830.14%14.95K
-467.45%-2.91K
+57.53%-237.00
+55.91%-906.00
-106.83%-2.05K
+81.32%-513.00
+87.27%-558.00
+68.85%-2.06K
+637.91%29.98K
-23.30%-2.75K
+41.44%-4.39K
+23.53%-6.60K
-37.54%-5.57K
-5.77%-2.23K
-17.00%-7.49K
-108.67%-8.63K
+0.39%-4.05K
-Change in Prepaid Assets
+100.00%0.00
+100.00%0.00
+2658.88%48.17K
-97.98%239.00
+98.22%-148.00
-101.84%-148.00
+121.56%1.75K
+117.16%11.81K
-425.66%-8.32K
-22.48%8.03K
+59.26%-8.10K
-68.67%5.44K
-124.51%-1.58K
+177.39%10.36K
-193.51%-19.87K
-65.95%17.35K
+105.23%6.45K
-324.32%-13.39K
+266.18%21.25K
--50.96K
-Change in Payables and Accrued Expense
-13.77%89.68K
-67.54%58.57K
+119.03%121.27K
+720.05%143.45K
+1302.97%104.00K
+72.44%180.45K
-91.23%55.37K
-97.81%17.49K
-98.41%7.41K
-18.98%104.64K
-8.27%631.13K
+154.46%799.61K
+641.07%467.61K
+1207.99%129.15K
+17813.54%688.03K
+1732.75%314.24K
+340.82%63.10K
+117.19%9.87K
-119.64%-3.88K
-137.11%-19.25K
Net cash flow from investing
----
----
----
----
----
----
----
----
----
----
----
----
----
----
+173.54%460.61K
+4.28%-316.29K
+26.52%-585.06K
+40.44%-491.20K
-209.27%-626.37K
+73.12%-330.43K
Net Cash Flow from Continuing Investing Activities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
+173.54%460.61K
+4.28%-316.29K
+26.52%-585.06K
+40.44%-491.20K
-209.27%-626.37K
+73.12%-330.43K
Net PPE Purchase and Sale
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--22.88
---57.78
Net Other Investing Changes
----
----
----
----
----
----
----
----
----
----
----
----
----
----
+173.53%460.61K
+4.26%-316.29K
---585.06K
---491.20K
---626.40K
---330.38K
Financing Cash Flow
+57.41%45.00K
-68.25%7.89K
+343.04%117.34K
-26.33%27.01K
-62.52%28.59K
-39.74%24.84K
-56.21%26.49K
+180.95%36.66K
-64.97%76.28K
-97.76%41.21K
-95.68%60.49K
-98.51%13.05K
-86.67%217.74K
+81.05%1.84M
+438.13%1.40M
-29.91%874.03K
-49.47%1.63M
-61.57%1.02M
-1349.66%-414.28K
-25.03%1.25M
Net Cash Flow from Continuing Financing Activities
+57.41%45.00K
-68.25%7.89K
+343.04%117.34K
-26.33%27.01K
-62.52%28.59K
-39.74%24.84K
-56.21%26.49K
+180.95%36.66K
-64.97%76.28K
-97.76%41.21K
-95.68%60.49K
-98.51%13.05K
-86.67%217.74K
+81.05%1.84M
+438.13%1.40M
-29.91%874.03K
-49.47%1.63M
-61.57%1.02M
-1349.66%-414.28K
-25.03%1.25M
Net Issuance Payments Of Debt
-100.00%0.00
-68.25%7.89K
+3.24%27.34K
-26.33%27.01K
-62.52%28.59K
-39.74%24.84K
-71.98%26.49K
+180.95%36.66K
--76.28K
--41.21K
--94.51K
--13.05K
--0.00
--0.00
--0.00
----
----
----
--0.00
----
Net Common Stock Issuance
----
----
----
----
----
----
----
----
----
----
-102.43%-34.02K
-100.00%0.00
-7.25%782.78K
+36.41%1.27M
+484.71%1.40M
+253.32%849.03K
-73.43%844.01K
-47.78%934.17K
-900.08%-364.12K
--240.30K
Proceeds from Stock Option Exercised
----
----
----
----
----
----
----
----
----
----
----
----
----
----
+100.00%0.00
-100.00%0.00
+301.99%790.04K
-88.56%81.78K
-740.52%-50.16K
--1.01M
Net Other Financing Charges
----
----
----
----
----
----
----
----
----
----
----
----
----
--565.03K
----
----
----
----
----
----
Ending Cash Balance
+2144.62%30.24K
+636.55%17.31K
+2638.11%94.41K
-18.30%4.84K
-97.41%1.35K
+3.43%2.35K
+6.65%3.45K
+0.92%5.92K
+1202.03%51.95K
-99.61%2.27K
-95.67%3.23K
-90.00%5.87K
-93.46%3.99K
+516.87%580.17K
-83.88%74.74K
-96.90%58.67K
-96.72%61.01K
-78.98%94.05K
+374.76%463.53K
+429.69%1.89M
Net Change in Cash
-185.41%-48.67K
-384.61%-44.58K
-82.92%66.02K
+80.32%-29.29K
+138.30%56.99K
+117.66%15.66K
+454.91%386.59K
-2268.44%-148.88K
+72.90%-148.79K
-114.97%-88.71K
-344.42%-108.92K
-286.25%-6.29K
-1598.62%-549.00K
+254.31%592.70K
+102.90%44.57K
-88.20%3.38K
-102.30%-32.32K
-210.02%-384.10K
-493.78%-1.54M
-91.91%28.61K
Beginning Cash Balance
+636.55%17.31K
+2638.11%94.41K
-18.30%4.84K
-97.41%1.35K
+3.43%2.35K
+6.65%3.45K
+0.92%5.92K
+1202.03%51.95K
-99.61%2.27K
-95.67%3.23K
-90.00%5.87K
-93.46%3.99K
+516.87%580.17K
-83.88%74.74K
-96.90%58.67K
-96.72%61.01K
-78.98%94.05K
+371.04%463.53K
+429.69%1.89M
+52320.28%1.86M
Effect of Exchange Rate Changes
+206.22%61.60K
-94.06%-32.53K
+106.05%23.55K
-68.12%32.79K
-129.22%-57.99K
-119.10%-16.76K
-466.05%-389.06K
+1159.67%102.85K
+830.19%198.47K
+200.53%87.75K
+473.05%106.29K
+242.92%8.17K
-3659.34%-27.18K
-697.20%-87.28K
---28.49K
---5.71K
---723.00
--14.62K
----
----
Free Cash Flow
-429.83%-93.67K
-471.84%-52.46K
-114.25%-51.32K
+69.66%-56.30K
+112.62%28.40K
+92.94%-9.17K
+312.56%360.10K
-850.73%-185.54K
+70.64%-225.07K
+89.58%-129.92K
+90.68%-169.41K
+96.48%-19.52K
+29.11%-766.56K
-37.17%-1.25M
-264.66%-1.82M
+37.58%-554.37K
-4.97%-1.08M
+38.21%-908.83K
+38.02%-498.24K
-1000.96%-888.11K
Deadline
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019
Dec 31, 2018
Sep 30, 2018
Jun 30, 2018
Mar 31, 2018
Dec 31, 2017
Sep 30, 2017
Accounting Standard
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
2022/Q22022/Q12021/Q42021/Q32021/Q22021/Q12020/Q42020/Q32020/Q22020/Q12019/Q42019/Q32019/Q22019/Q12018/Q42018/Q32018/Q22018/Q12017/Q42017/Q3

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.